Page last updated: 2024-09-03

n(6)-carboxymethyllysine and rhodanine

n(6)-carboxymethyllysine has been researched along with rhodanine in 1 studies

Compound Research Comparison

Studies (n(6)-carboxymethyllysine)	Trials (n(6)-carboxymethyllysine)	Recent Studies (post-2010) (n(6)-carboxymethyllysine)	Studies (rhodanine)	Trials (rhodanine)	Recent Studies (post-2010) (rhodanine)
803	44	365	549	22	232

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamada, Y; Horiuchi, S; Hotta, N; Kasuya, Y; Kato, K; Komori, T; Nagai, R; Nakamura, J; Naruse, K	1

Other Studies

1 other study(ies) available for n(6)-carboxymethyllysine and rhodanine

Article	Year
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes care, 2000, Volume: 23, Issue:10 Topics: Aldehyde Reductase; Blood Glucose; Blood Proteins; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Reference Values; Rhodanine; Thiazolidines	2000

Article

Year

Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.

Diabetes care, 2000, Volume: 23, Issue:10

Topics: Aldehyde Reductase; Blood Glucose; Blood Proteins; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Reference Values; Rhodanine; Thiazolidines

2000